期刊文献+

17-AAG通过抑制Erk信号通路增强奥沙利铂诱导结肠癌细胞凋亡 被引量:2

17-Allylamino-17-demethoxygeldanamycin Enhances Apoptosis Induced by Oxaliplatin via Suppression of Erk Signaling Pathway in RKO Colon Cancer Cell Line
下载PDF
导出
摘要 目的研究17-AAG与奥沙利铂是否存在协同效应,并探讨PI3K/Akt、Erk信号通路在奥沙利铂联合17-AAG诱导人结肠癌细胞凋亡过程中的作用。方法四甲基偶氮唑盐比色实验(MTT法)检测17-AAG、奥沙利铂对细胞增殖的抑制作用;流式细胞术分析细胞凋亡情况;Western blot法检测相关蛋白的表达水平。结果 17-AAG能抑制RKO细胞的增殖;17-AAG联合奥沙利铂作用于RKO细胞24h后,G2/M期细胞比例及凋亡率明显增加;奥沙利铂抑制p-Akt、p-Erk的活化,上调Bax,下调Bcl-2蛋白表达,活化裂解Caspase-3,联合使用17-AAG后可进一步增强上述作用,但对PI3K/Akt信号通路影响不大。结论本实验表明17-AAG具有增强奥沙利铂诱导结肠癌RKO细胞凋亡的作用,同时也说明17-AAG与奥沙利铂存在协同效应;17-AAG上调Bax,下调Bcl-2蛋白表达及增强奥沙利铂对Erk信号通路的抑制作用可能是其促进凋亡的重要机制之一。 Objective To determine whether there was a synergistic effect between the Hsp90 inhibitor 17-AAG and oxaliplatin and to further investigate the roles of PI3K/Akt and Erk in apoptosis induced with 17-AAG and oxaliplatin treatment in a human colon cancer cell line.Methods Colorimetric 3-[4,5-dimethy thiazol-2-yl]-2,5-diphenyl tetrazolium bromide(MTT) assay was used to study the inhibitory effect on proliferation of RKO cell treated with 17-AAG and oxaliplatin,Apoptosis was evaluated by flow cytometry;Western blot was carried out to determine protein expression levels.Results 17-AAG could definitely inhibit the of RKO cells.When the RKO cells were exposed to 17-AAG combined with oxaliplatin for 24 h,G2/M ratio and apoptosis rates were significantly increased.Oxaliplatin significantly decreased the protein expression of p-Akt and p-Erk.Oxaliplatin was also found to significantly increase the protein expression of Bax and Caspase-3 and to decrease the expression of Bcl-2.All these effects were enhanced when identical experiments were carried out in the presence of 17-AAG,but it had no apparent effects on the PI3K/Akt signaling pathway.Conclusion 17-AAG enhances apoptosis induced by oxaliplatin in RKO cells and there maybe exist a synergistic effect between 17-AAG and oxaliplatin.The increased expression of Bax,the decreased expression of Bcl-2 and the inhibition of Erk signaling pathway may be the underlying mechanisms leading to apoptosis.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2013年第8期752-757,共6页 Cancer Research on Prevention and Treatment
基金 辽宁省科技厅科学技术计划项目(2011225015) 辽宁省教育厅一般项目(L2010277)
关键词 结肠癌 17-丙烯胺基-17-去甲氧基格尔德霉素 奥沙利铂 凋亡 PI3K Akt ERK Colon cancer 17-allylamino-17-demetho XYgeldanamycin(17-AAG) Oxaliplatin Apoptosis PI3K/Akt Erk
  • 相关文献

参考文献12

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics,2012[J]. CA Cancer J Clin, 2012, 62 ( 1 ) : 10-29.
  • 2Zhang J, Zheng Z, Zhao Y, et al. The heat shock protein 90 inhibitor 17-AAG suppresses growth and induces apoptosis in human cholangiocarcinoma cells[J]. Clin Exp Med, 2012, [Epub ahead of print].
  • 3Prewett M, Deevi DS, Bassi R,et al. Tumors established with cell lines selected for oxaliplatin resistance respond to oxalipla- tin if combined with cetuximab[J]. Clin Cancer Res, 2007, 13 (24) : 7432-40.
  • 4Usmani SZ, Bona R, Li Z. 17 AAG for HSP90 inhibition in cancer--from bench to bedside[J]. Curr Mol Med, 2009,9(5) 654-64.
  • 5Blagosklonny MV. p53 from complexity to simplceity: mutant p53 stabilization, gain-of-function, and dominant negative effect[J]. FASEB J, 2000, 14(13) : 1901-7.
  • 6Arlander SJ, Eapen AK, Vroman BT, et al. Hsp90 inhibition depletes Chkl and sensitizes tumor cells to replication stress [J]. J Biol Chem, 2003, 278(52):52572-7.
  • 7MOnster PN, Basso A, Solit D, et al. Modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemo therapy induced apoptosis in an RB- and schedule-dependent manner[J]. Clin Cancer Res, 2001, 7(8) :2228 36.
  • 8Rakitina TV, Vasilevskaya IA, O'Dwyer PJ. Inhibition of G1/S transition potentiates oxaliplatin-induced cell death in colon cancer cell lines [J].Biochem Pharmacol, 2007, 73 ( 11 ) : 1715-26.
  • 9Prodromou C, Pearl LH. Structure and functional relationships of Hsp90[J]. Curr Cancer Drug Targets, 2003, 3(5) :301-23.
  • 10Bedin M, Gaben AM, Saucier C, et al. Oeldanamycin, anin- hibitor of the ehaperone activity of Hsp90, induces MAPK-in dependent cell cycle arrest[J]. Int J Cancer, 2004, 109(5): 643-52.

同被引文献31

  • 1黄海辉,梁后杰,胡绍毅,边志衡,何建明.磷脂酰肌醇3激酶信号通路影响细胞凋亡在肺腺癌A549细胞群集耐药中的作用[J].第三军医大学学报,2004,26(9):756-758. 被引量:8
  • 2乔玉环,程佳,郭瑞霞.卵巢上皮性癌组织中磷酸化蛋白激酶B和PTEN蛋白的表达及其意义[J].中华妇产科杂志,2007,42(5):325-329. 被引量:22
  • 3OConnor ES, Greenblatt DY, Loconte NK, et al. Adjuvant chemo- therapy for stage 1I colon cancer with poor prognostic features [ J]. J Clin Onco1,201 1,29 (25) :3381-3388.
  • 4Hutchins G, Southward K, Handley K, et al. Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer [ J ]. J Clin On- col,2011,29(10) :1261-1270.
  • 5Merkel S, Wein A, Gunther K, et al. High-risk groups of patients with Stage lI colon carcinoma [J]. Cancer, 2001,92 ( 6 ) : 1435- 1443.
  • 6Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of rec- ommendations for the use of tumor markers in gastrointestinal cancer[J]. J Clin Oncol,2006,24 ( 33 ) :5313-5327.
  • 7Huh JW, Oh BR, Kim HR, et al. Preoperative earcinoembryonie antigen level as an independent prognostic factor in potentially curative colon cancer[ J ]. J Surg Oneol,2010,101 ( 5 ) :396-400.
  • 8Peng Y, Wang L, Gu J. Elevated preoperative carcinoembryonic antigen(CEA) and Ki67 is predictor of decreased survival in IIA stage colon cancer[ J ], World J Surg,2012,37 (1) :208-213.
  • 9Yeh CY, Hsieh PS, Chiang JM, et al. Preoperative carcinoembry- onic antigen elevation in colorectal cancer[J]. Hepatogastroenter- ology,2011,58 ( 109 ) : 1171-1176.
  • 10Parenti A, Leo G, Porzionato A, et al. Expression of survivin, p53, and caspase 3 in Barrett' s esophagus carcinogenesis [ J ]. Hum Patho1,2006,37 : 16 - 22.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部